BioGPT

Microsoft · 2022 · Science/Biology · USA

A to Z

A · App: No
B · Built By: Microsoft
C · CEO & Politics: Satya Nadella — Centrist / moderate
D · Date: 2022
E · Expertise: Intermediate+
F · Free Tier: Yes
G · Generates: Text only
H · Deployment: Cloud + Local (open weights)
I · Inputs: Text
J · Jurisdiction: USA
K · Key Staffers: Mustafa Suleyman (CEO Microsoft AI), Kevin Scott (CTO)
L · Languages: English-primary
M · Model Type: Science/Biology
N · Safety Issues: None reported
O · Open Source: Yes — open weights
P · Pricing: Free (open weights, MIT)
Q · AIDb Rating: [UNKNOWN]
R · What Makes It Special: Microsoft Research's BioGPT (October 2022), a domain-specific generative Transformer language model pre-trained on large-scale biomedical literature, built because BERT-style biomedical models such as BioBERT and PubMedBERT cannot generate text; it outperformed previous models on most of six biomedical NLP tasks, setting a record 78.2% accuracy on PubMedQA and F1 scores of 44.98% on BC5CDR, 38.42% on KD-DTI and 40.76% on DDI relation extraction. MIT license.
S · Stock / Status: $516 (MSFT, Sep 25, 2026)
T · Training Cutoff: [UNKNOWN]
U · Users: [UNKNOWN]
V · Voice Chat: No
W · Weights: Downloadable
X · X Handle: @Microsoft
Y · Year Founded: [UNKNOWN]
Z · Bottom Line: Open-weights Science/Biology from Microsoft, released 2022.

Data completeness 85% · Last verified 2026-05-12 · Primary source ↗

“BioGPT.” AIDb — The AI Database. Verified 2026-05-12. https://theaidatabase.com/m/biogpt.html